Your browser doesn't support javascript.
loading
Recent Advances in Dual PI3K/mTOR Inhibitors for Tumour Treatment.
Wu, Xianbo; Xu, Yihua; Liang, Qi; Yang, Xinwei; Huang, Jianli; Wang, Jie; Zhang, Hong; Shi, Jianyou.
Afiliación
  • Wu X; School of Sports Medicine and Health, Chengdu Sport University, Chengdu, China.
  • Xu Y; School of Basic Medical Science, Chengdu University of Traditional Chinese Medicine, Chengdu, China.
  • Liang Q; College of Medicine, Southwest Jiaotong University, Chengdu, China.
  • Yang X; School of Sports Medicine and Health, Chengdu Sport University, Chengdu, China.
  • Huang J; First Clinical College of Medicine, Guizhou University of Traditional Chinese Medicine, Guiyang, China.
  • Wang J; First Clinical College of Medicine, Guizhou University of Traditional Chinese Medicine, Guiyang, China.
  • Zhang H; Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu, China.
  • Shi J; Personalized Drug Therapy Key Laboratory of Sichuan Province, Sichuan Academy of Medical Science and Sichuan Provincial People's Hospital, School of Medicine of University of Electronic Science and Technology of China, Chengdu, China.
Front Pharmacol ; 13: 875372, 2022.
Article en En | MEDLINE | ID: mdl-35614940
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Idioma: En Revista: Front Pharmacol Año: 2022 Tipo del documento: Article País de afiliación: China
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Idioma: En Revista: Front Pharmacol Año: 2022 Tipo del documento: Article País de afiliación: China